Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
- 1 February 2003
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 9 (2), 152
- https://doi.org/10.1038/nm0203-152
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Predicting the future of breast cancerNature Medicine, 2003
- Cyclin E and Survival in Patients with Breast CancerNew England Journal of Medicine, 2002
- Revision of the American Joint Committee on Cancer Staging System for Breast CancerJournal of Clinical Oncology, 2002
- The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinomaCancer, 2000
- The prognosis of small primary breast cancersEuropean Journal Of Cancer, 1999
- Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery aloneCancer, 1991